Elanco Animal Health Incorporated (NYSE:ELAN) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET

Company Participants

Katy Grissom - Head, Investor Relations
Jeff Simmons - President & CEO
Todd Young - EVP & CFO

Conference Call Participants

Michael Ryskin - Bank of America Merrill Lynch
Jonathan Block - Stifel
Erin Wright - Morgan Stanley
Brandon Vazquez - William Blair
Balaji Prasad - Barclays
Chris Schott - JPMorgan
Mike DiFiore - Evercore ISI
David Westenberg - Piper Sandler
Navann Ty - BNP Paribas

Operator

Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Thank you. I would now like to hand the call over to Katy Grissom, Head of Investor Relations. You may begin your conference.

Katy Grissom

Good morning. Thank you for joining us for Elanco Animal Health third quarter 2024 earnings call. I'm Katy Grissom, Head of Investor Relations and ESG. Joining us on today's call are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; and Beth Haney from Investor Relations. The slides referenced during this call are available on the Investor Relations section of elanco.com. Today's discussion will include forward-looking statements. These statements are based on our current assumptions and expectations and are subject to risks and uncertainties that could cause actual results to differ materially from our forecast.

For more information, see the risk factors in today's earnings press release as well as our latest Form 10-K and 10-Q filed with the SEC. We do not undertake any duty to update any forward-looking statements. The information we provide about our products and pipeline is for the benefit of the investment community. It is not intended to be promotional, and it is not sufficient for prescribing decisions.

Our remarks today will focus on our non-GAAP financial measures. Reconciliations of these non-GAAP measures are included in the appendix of today's slides and in the earnings press release. After our prepared remarks, we will be happy to take your questions. I'll now turn the call over to Jeff.

Jeff Simmons

Thanks, Katy. Good morning, everyone. Elanco reported a strong third quarter, delivering constant currency organic top line growth with adjusted EBITDA and adjusted EPS above the midpoint of our guidance ranges. Organic constant currency revenue growth of 1% was driven by the contribution from new products, led by Experior, AdTab, Credelio Plus and Zenrelia. This marks our fifth consecutive quarter of growth in our underlying business, and we continue to expect to deliver constant currency organic revenue growth of about 3% in 2024.